Invention Grant
- Patent Title: Cell-permeable peptide inhibitors of the JNK signal transduction pathway
-
Application No.: US12101911Application Date: 2008-04-11
-
Publication No.: US08236924B2Publication Date: 2012-08-07
- Inventor: Christophe Bonny
- Applicant: Christophe Bonny
- Applicant Address: CH Lausanne
- Assignee: Xigen SA
- Current Assignee: Xigen SA
- Current Assignee Address: CH Lausanne
- Agency: Morgan Lewis & Bockius LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61P17/14
Abstract:
The invention provides cell-permeable peptides that bind to JNK proteins and inhibit JNK-mediated effects in JNK-expressing cells.
Public/Granted literature
- US20090069234A1 CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY Public/Granted day:2009-03-12
Information query
IPC分类:
